EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective

Leslie Marisol Gonzalez-Hermosillo iD, Guillermo Cueto-Robledo, Dulce Iliana Navarro-Vergara iD, Maria Berenice Torres-Rojas, Marisol García-Cesar, Oscar Pérez-Méndez iD, Galileo Escobedo iD

Advances in Respiratory Medicine · 27.11.2024 · 92 (6) · 485-503

DOI: 10.3390/arm92060044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 27.11.2024. Verfasst von Leslie Marisol Gonzalez-Hermosillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Embolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Division of the General Hospital of Mexico “Dr. Eduardo Liceaga”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but severe condition characterized by persistent obstruction and vascular remodeling in the pulmonary arteries following an acute pulmonary embolism (APE). Although APE is a significant risk factor, up to 25% of CTEPH cases occur without a history of APE or deep vein thrombosis, complicating the understanding of its pathogenesis. Herein, we carried out a narrative review discussing the mechanisms involved in CTEPH development, including fibrotic thrombus formation, pulmonary vascular remodeling, and abnormal angiogenesis, leading to elevated pulmonary vascular resistance and right heart failure. We also outlined how the disease’s pathophysiology reveals both proximal and distal pulmonary artery obstruction, contributing to the development of pulmonary hypertension. We depicted the risk factors predicting CTEPH, including thrombotic history, hemostatic disorders, and certain medical conditions. We finally looked at the molecular mechanisms behind the role of endothelial dysfunction, gene expression alterations, and inflammatory processes in CTEPH progression and detection. Despite these insights, there is still a need for improved diagnostic tools, biomarkers, and therapeutic strategies to enhance early detection and management of CTEPH, ultimately aiming to reduce diagnostic delay and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryPulmonary EmbolismHumansChronic DiseaseRisk Factors

Stichwörter der Autor:innen

acute pulmonary embolismchronic thromboembolic pulmonary hypertensionfibrotic thrombus formationgene expressionpulmonary hypertensionpulmonary vascular remodeling

Autor:innen und Institutionen

  • Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico.
  • Cardiorespiratory Emergency Department, Pulmonary Hypertension Clinic, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico.
  • Doctorate Program in Biomedical Sciences, Postgraduate Unit, National Autonomous University of Mexico, Mexico City 04510, Mexico.
  • Tecnológico de Monterrey, School of Engineering and Sciences, Mexico City 14380, Mexico.
  • Departamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.

ORCID-Profile: Leslie Marisol Gonzalez-Hermosillo, Dulce Iliana Navarro-Vergara, Oscar Pérez-Méndez, Galileo Escobedo

Förderung

  • Research Division of the General Hospital of Mexico “Dr. Eduardo Liceaga”

Zitieren

APA

Gonzalez-Hermosillo, L. M., Cueto-Robledo, G., Navarro-Vergara, D. I., Torres-Rojas, M. B., García-Cesar, M., Pérez-Méndez, O., & Escobedo, G. (2024). Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective. Advances in Respiratory Medicine, 92(6), 485-503. https://doi.org/10.3390/arm92060044

Vancouver

Gonzalez-Hermosillo LM, Cueto-Robledo G, Navarro-Vergara DI, Torres-Rojas MB, García-Cesar M, Pérez-Méndez O, et al. Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective. Advances in Respiratory Medicine. 2024;92(6):485-503. doi:10.3390/arm92060044

BibTeX
@article{GonzalezHermosillo2024,
  author = {Gonzalez-Hermosillo, Leslie Marisol and Cueto-Robledo, Guillermo and Navarro-Vergara, Dulce Iliana and Torres-Rojas, Maria Berenice and García-Cesar, Marisol and Pérez-Méndez, Oscar and Escobedo, Galileo},
  title = {Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective},
  journal = {Advances in Respiratory Medicine},
  year = {2024},
  volume = {92},
  number = {6},
  pages = {485--503},
  doi = {10.3390/arm92060044}
}
Kostenlos starten →